Table 1.
Baseline characteristics of the study population.
| Total (n = 239) |
YBG (n = 40) |
SBG (n = 40) |
OBG (n = 40) |
AX (n = 40) |
EPS (n = 39) |
CTRL (n = 40) |
p-Value | |
|---|---|---|---|---|---|---|---|---|
| Female/male (n) | 118/121 | 17/23 | 19/21 | 23/17 | 22/18 | 23/16 | 14/26 | 0.212 |
| Age (years) | 67.9 [63.1; 71.4] | 68.2 [62.1; 71.2] | 67.3 [60.2; 70.0] | 68.0 [63.0; 71.3] | 67.5 [63.7; 71.3] | 66.2 [62.2; 72.3] | 69.5 [65.0; 73.3] | 0.271 |
| BMI (kg/m2) | 27.0 ± 3.6 | 27.2 ± 3.9 | 27.0 ± 3.1 | 26.9 ± 3.5 | 26.7 ± 4.0 | 27.3 ± 3.7 | 27.3 ± 3.5 | 0.969 |
Values are presented as numbers, medians [Q1; Q3], or mean ± SD. Differences in sex between intervention groups were tested with a Chi-square test. Differences in age were tested with a Kruskal–Wallis test and differences in BMI were tested with one-way ANOVA. BMI: body mass index, YBG: yeast β-glucan, SBG: shiitake β-glucan, OBG: oat β-glucan, AX: arabinoxylan, EPS: exopolysaccharide, CTRL: control.